1 online
 
Change language:    
Menu

4202011_email_gmail_mail_logo_social_icon.png  4102573_applications_facebook_media_social_icon.png  11244080_x_twitter_elon_musk_twitter_new_logo_icon.png  5296501_linkedin_network_linkedin_logo_icon.png  386762_youtube_video_you_tube_icon.png


Vyhledávání v abstraktech

Sponzor



PROHLÍŽENÍ ABSTRAKTA

STRUCTURE, EFFICACY AND ECONOMY OF THE THERAPY OF HYPERTENSION IN SLOVAK OUT-WARD PATIENTS WITH METABOLIC SYNDROME – PROJECT NEMESYSRNRN
Tématický okruh:
Typ: Poster - lékařský , Číslo v programu: 52

Lietava J.1, Kosmálová V.1, Čaprnda M.1, Turek P.2, Fodor G.3

1 II.interná klinika, Fakultná nemocnice, Bratislava, SR, 2 ., 3 Heart Institute, University of Ottawa, Ottawa, Canada


Introduction. Increased blood pressure is one of discriminant criteria for presence of metabolic syndrome (MS). Despite of  numerous analyses of antihypertensive therapy,  its evaluation in association to MS are seldom.
Method: Crosssectional multicentric screening of MS and structure of medication was performed in  8679 consequetive out-ward patients in whole territory of Slovakia. MS
was defined according to IDF criteria (IDF 2005).
Results. Out-ward patients aged 52.4±16.1 yrs [17-96 yrs] exhibited 25.6% prevalence of  MS (23.7% in males; 26.9% in females; p<0.01). Hypertension (BP≥140/90 mmHg) or antihypertensive therapy  were present in 65.8% pts. Target blood pressure for MS [BP <130/85 mm Hg] was reached in 13.3% of MS+ pts and 14.7% of MS- of treated hypertensive patients (NS). MS + pts were more often unsuccessfully treated (70.1% vs. 54.4%; p<0.001). Both subgroups had similar structure of therapy, however, MS+ pts were treated more expensively – antihypertensive therapy was 14.9 vs 13.1 SK of  DDD (p<0.001); hypolipodemic therapy was 12.3 vs 10.7 SK of DDD (p<0.001); and whole therapy was 34.7 vs 30.3 SK of DDD (p<0.01).
Conclusion: Project NEMESYS found 25.6% prevalence of  metabolic syndrom between out-ward patients. Their antihypertensive and hypolipidemic therapies were more expensive and equally efficient (resp. non.efficient) in comparison with patients without MS. Only 14% of pts reached normotension.